Glenmark Pharmaceuticals

CCI approves Nirma’s acquisition of 75% stake in Glenmark Life Sciences

CCI approves Nirma’s acquisition of 75% stake in Glenmark Life Sciences

21 Dec 2023

The Competition Commission of India (CCI) has approved acquisition of majority shareholding of Glenmark Life Sciences (GLS) Limited by the Nirma Limited.

Glenmark’s nasal spray granted marketing approval in India

16 May 2022

US FDA approves Glenmark's oral contraceptives

24 Feb 2016

Glenmark to raise Rs 945 crore from Temasek Holdings

17 Apr 2015

HC blocks Glenmark from selling US firm’s diabetes drug

20 Mar 2015

A bench of Justices S Ravindra Bhat and Najmi Waziri, while granting the interim injunction, said Merck Sharp and Dohme "has established a prima facie case of patent infringement" by Glenmark

Glenmark recalls anti-ulcer drug in the US over tablet mix-up

19 Apr 2014

Glenmark Pharmaceuticals Ltd is recalling 2,900 bottles of its anti-ulcer drug ranitidine from the US market after a tablet to treat high blood pressure was found in one of the bottles

Glenmark receives US health regulator approval for Riluzole tablets

19 Jun 2013

Delhi HC refuses interim relief to Merck over Glenmark drug

05 Apr 2013

Glenmark said the US drug firm has no patent rights over ‘Sitagliptin Phosphate’, which is used in its anti-diabetes drugs Zita and Zita-Met

Glenmark wins favourable interim order in deal with Napo

14 Jan 2012

In a significant positive for Glenmark Pharmaceuticals Ltd, its US partner in a drug development and marketing agreement, Napo Pharmaceuticals Inc, will not be able to terminate a deal thanks to an arbitration order

Glenmark to market Crofelemer despite Napo nix

15 Dec 2011

Glenmark files arbitration claims for Crofelemer against Napo

08 Aug 2011

Glenmark Pharma gets US FDA Final Approval For Nizatidine Capsules

18 Jul 2011

Glenmark sells new drug licence to Sanofi for $50 mn

17 May 2011

In addition, Glenmark could receive potential success-based development, regulatory and commercial milestone payments of up to $613 million, subject to the drug getting past the remaining phases of human trials

Glenmark Pharma files application of human trial in Netherlands for GRC 17536 molecule

17 Feb 2011

US FDA approves Glenmark's corticosteroid

10 Aug 2010

Glenmark enters into a settlement and license agreement with Sepracor Inc

09 Aug 2010

Glenmark Generics receives approval from the USFDA for Norethindrone tablets 0.35mg

23 Jul 2010

Merck settles Zetia patent suit with Glenmark

11 May 2010

Glenmark's US subsidiary gets US FDA approval for Tarka generic

10 May 2010

Glenmark Generics licenses branded drug to Taro USA

06 May 2010

Glenmark in $325-million drug deal with Sanofi-Aventis

03 May 2010

Under the terms of the agreement, Glenmark will receive an upfront payment as well as development, regulatory and commercial milestone payments, that could reach a total of $325 million

Glenmark launches Prasugrel for heart patients in India

29 Apr 2010

Glenmark settles malaria drug patent dispute with GlaxoSmithKline

12 Apr 2010

Glenmark launches two new generics in UK

07 Apr 2010

FDA accepts Glenmark’s painkiller oxycodone hydrochloride for review

01 Apr 2010

View details about the software product Informachine News Trackers